Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-024530
Filing Date
2025-03-17
Accepted
2025-03-17 18:35:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 21676
2 EXHIBIT 7.01 tm259462d1_ex7-01.htm EX-7.01 6898
3 EXHIBIT 7.02 tm259462d1_ex7-02.htm EX-7.02 10310
  Complete submission text file 0001104659-25-024530.txt   40630
Mailing Address
Business Address 511 BENEDICT AVE. TARRYTOWN NY 10591-5097
BAYER HEALTHCARE LLC (Filed by) CIK: 0001231517 (see all company filings)

EIN.: 061653795 | State of Incorp.: DE
Type: SCHEDULE 13D

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Subject) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92581 | Film No.: 25745954
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)